Cardiovascular disease therapeutics via engineered oral microbiota: Applications and perspective.
Zhen W, Wang Z, Wang Q, Sun W, Wang R, Zhang W, Zhang Y, Qin W, Li B, Wang Q, Hong B, Yang Y, Xu J, Ma S, Da M, Feng L, Zang X, Mo X, Sun X, Wu M, Xu J, Xu J, Huang Y, Zhang H.
Zhen W, et al.
Imeta. 2024 May 9;3(3):e197. doi: 10.1002/imt2.197. eCollection 2024 Jun.
Imeta. 2024.
PMID: 38898992
Free PMC article.